AIRAmed

AIRAmed is a German medical technology company specializing in AI-driven software for the automated analysis of brain MRI scans. The company's flagship product, AIRAscore, provides precise quantification of brain volume and compares it to a large reference database to assist in the early detection and monitoring of neurodegenerative diseases such as Alzheimer's and Multiple Sclerosis. By transforming qualitative imaging into quantitative data, AIRAmed enables radiologists and neurologists to make more objective diagnoses and track disease progression with high sensitivity. The software is CE-marked and FDA-cleared, facilitating its integration into clinical workflows globally.